Skip to main content
SpringerLink
Log in

Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

There are few data about the reliability of sentinel node biopsy in patients with multi-focal breast cancer. The aim of this study was to determine the factors affecting the identification and accuracy of the sentinel node, comparing multifocality with other variables, using peritumoral isosulfan blue dye injection technique alone. Between 1998 and 2001, 122 patients with clinically negative nodes from a single institute were eligible for sentinel lymph node biopsies (SLNBs). All patients underwent conventional axillary lymph node dissection (ALND). SLNs were identified in 111 of 122 (91%) cases, and analyzed by hematoxylin and eosin. Twenty-one patients with multi-focal breast cancer were determined by clinical or pathologic examination (gross or microscopic). Success in locating the sentinel node was unrelated to patient's age, tumor size, type, location, histological or nuclear grade, multifocality, or a previous surgical biopsy. SLNBs accurately predicted the status of the axilla in 104 of the 111 patients (93.7%), while 18 of the 21 patients with multi-focal breast cancer (85.7%) had successful lymphatic mapping. The false negative (FN) rate was 11.3% among patients with successful SLNBs. Multifocality and tumor size (>2 cm) were associated significantly with decreased accuracy and increased FN rates (for multifocality, p = 0.007 and p = 0.006, and for tumor size >2 cm, p = 0.04 and p = 0.05, respectively) in binary logistic regression analysis, whereas excisional biopsy, tumor location in the upper outer quadrant and patient's age did not significantly affect the accuracy and FN rates in univariate analysis. These results suggest sentinel lymph node biopsy using peritumoral isosulfan blue injection method alone can accurately predict axillary status in patients with clinically negative nodes, but patients with multi-focal disease and large tumor size may not be ideal candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer results of a national survey by the American College of Surgeons. Cancer 45: 2917–2924, 1980

    PubMed  Google Scholar 

  2. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181–187, 1989

    PubMed  Google Scholar 

  3. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88: 608–614, 2000

    PubMed  Google Scholar 

  4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–401, 1994

    PubMed  Google Scholar 

  5. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, De Cicco C, Geraghty JG, Lui Sacchini V, Veronisi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–1867, 1997

    PubMed  Google Scholar 

  6. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 339: 941–946, 1998

    PubMed  Google Scholar 

  7. Hill ADK, Tran KM, Adhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HS 3rd: Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229: 528–535, 1999

    PubMed  Google Scholar 

  8. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349: 1668–1669, 1997

    Google Scholar 

  9. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368–373, 1999

    PubMed  Google Scholar 

  10. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186: 275–283, 1998

    PubMed  Google Scholar 

  11. Haigh PI, Hansen NM, Qi K, Giuliano AE: Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7: 21–27, 2000

    PubMed  Google Scholar 

  12. Koller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa MZ: Sentinel lymph node involvement-a predictor for axil-lary nodal status with breast cancer-has the time come? Eur J Surg Oncol 24: 166–168, 1998

    PubMed  Google Scholar 

  13. Bass SS, Dauway E, Mahatme A, Ku NN, Berman C, Reintgen D, Cox CE: Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancer <1 centimeter (T1a-T1b). Am Surg 65: 857–861, 1999

    PubMed  Google Scholar 

  14. Kollias J, Gill PG, Chatterton BE, Hall VE, Bochner MA, Coventry BJ, Farshid G: Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer. Med J Aust 171: 461–465, 1999

    PubMed  Google Scholar 

  15. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17: 1720–1726, 1999

    PubMed  Google Scholar 

  16. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC: Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84: 138–142, 1999

    PubMed  Google Scholar 

  17. Reintgen D, Joseph E, Lyman GH, Yeatman T, Balducci L, Ku NN, Berman C, Shons A, Wells K, Horton J, Grennberg H, Nicosia S, Clark R, Shivers S, Li W, Wang X, Cantor A, Cox C: The role of selective lymphadenectomy in breast cancer. Cancer Cont 4: 211–219, 1997

    Google Scholar 

  18. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, Koyama H: Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 76: 95–99, 2001

    PubMed  Google Scholar 

  19. Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol 62: 75–77, 1996

    PubMed  Google Scholar 

  20. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lymon GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645–653, 1998

    PubMed  Google Scholar 

  21. Cody HS III: Sentinel lymph node mapping in breast cancer. Breast Cancer 6: 13–22, 1999

    PubMed  Google Scholar 

  22. Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, Hansen N: Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 126: 714–722, 1999

    PubMed  Google Scholar 

  23. Schrenk P, Wayand W: Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 357: 122, 2001

    PubMed  Google Scholar 

  24. Mertz L, Mathelin C, Marin C, Gairard B, Chenard MP, Brettes JP, Bellocq JP, Constantinesco A: Subareolar injection of 99mTc sulfur colloid for sentinel node identification in multifocal invasive breast cancer. Bull Cancer 86: 939–945, 1999

    PubMed  Google Scholar 

  25. Fernandez K, Swanson M, Verbanac K, Tafra L: Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer. Ann Surg Oncol 9(Suppl): S16-S17 (abstract 29), 2002

    Google Scholar 

  26. Ross MI: Sentinel node dissection in early-stage breast cancer: Ongoing prospective randomized trials in the USA. Ann Surg Oncol 8: 77–81, 2001

    Google Scholar 

  27. Grube BJ, Hansen N, Giuliano AE: Feasibility of sentinel lymph node (SLN) determination in lobular carcinoma of the breast. In: Abstract Book. The Society of Surgical Oncology, 54th Annual Cancer Symposium,Washington DC, March 15–18, 2001, p. 42 (P32)

  28. Olson JA Jr, Fey J, Winawer J, Borgen PI, Cody HS 3rd, Van Zee KJ, Petrek J, Heerdt AS: Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 191: 593–599, 2000

    PubMed  Google Scholar 

  29. Cox CE, Bass SS, McCann CR, Ku NN, Berman C, Durand K, Bolano M, Wang J, Peltz E, Cox S, Salud C, Reintgen DS, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med 51: 525–542, 2000

    PubMed  Google Scholar 

  30. Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K: A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63: 31–40, 2000

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Istanbul Medical Faculty, Istanbul University, Turkey

    Vahit Ozmen, Mahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, Mustafa Kecer, Yavuz Bozfakioglu & Temel Dagoglu

  2. Department of Pathology, Istanbul Medical Faculty, Istanbul University, Turkey

    Sitki Tuzlali & Ridvan Ilhan

Authors
  1. Vahit Ozmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahmut Muslumanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neslihan Cabioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sitki Tuzlali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ridvan Ilhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abdullah Igci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mustafa Kecer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yavuz Bozfakioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Temel Dagoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozmen, V., Muslumanoglu, M., Cabioglu, N. et al. Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer. Breast Cancer Res Treat 76, 237–244 (2002). https://doi.org/10.1023/A:1020890921238

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020890921238

Search

Navigation